Expected benefits from new technology include more efficient patient selection for clinical
trials, more cost-effective treatment pathways for patients and health services and a more …

Regulatory authorities expect the pharmaceutical and biotechnology industries to accelerate
their development of companion diagnostics and companion therapeutics towards the goal …

Precision medicine has evolved from the application of pharmacogenetic biomarkers to the
prospective development of targeted therapies in patients with specific molecular/genetic …

The proposed value of personalized medicine is currently well understood. With an
increased study of the molecular basis of disease, the development of drugs that are highly …

Evaluating the prospects for 'personalized healthcare 'has become topical at the 10-year
anniversary of the first results from the Human Genome Project. The coincidence of this …

drugs? This focus on drug action and disposition provided the fundamental algorithms of
personalized medicine in which the right drug is used in the right patient at the right dose (for …

Personalized medicine has reached the mainstream, accounting for more new drug
approvals and a promising pipeline of candidate therapeutics. Recent advances in …

The number of personalized medicines and companion diagnostics in use in the United
States has gradually increased over the past decade, from a handful of medicines and tests …

Personalized medicine is the tailoring of therapies to defined subsets of patients based on
their likelihood to respond to therapy or their risk of adverse events. The advent of improved …

Application of personalized medicine in drug development and regulation has been limited
by similar logistical, informatics, and cultural barriers that limit use of pharmacogenetics in …